Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide

J Med Chem. 2008 Mar 27;51(6):1791-9. doi: 10.1021/jm701264d. Epub 2008 Feb 28.

Abstract

We present here the first synthesis of organometallic complexes derived from the nonsteroidal antiandrogen nilutamide, bearing a ferrocenyl substituent at position N(1) or at C(5) of the hydantoin ring; for comparison, we also describe the C(5) p-anisyl organic analogue. All of these complexes retain a modest affinity for the androgen receptor. The N-substituted complexes show a weak or moderate antiproliferative effect (IC 50 around 68 microM) on hormone-dependent and -independent prostate cancer cells, while the C(5)-substituted compounds exhibit toxicity levels 10 times higher (IC 50 around 5.4 microM). This strong antiproliferative effect is probably due to a structural effect linked to the aromatic character of the ferrocene rather than to its organometallic feature. In addition, it seems connected to a cytotoxic effect rather than an antihormonal one. These results open the way toward a new family of molecules that are active against both hormone-dependent and hormone-independent prostate cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgen Antagonists / chemical synthesis*
  • Androgen Antagonists / chemistry
  • Androgen Antagonists / pharmacology*
  • Anilides / chemistry
  • Anilides / pharmacology
  • Binding, Competitive
  • Cell Proliferation / drug effects
  • Crystallography, X-Ray
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Ferrous Compounds / chemical synthesis*
  • Ferrous Compounds / chemistry
  • Ferrous Compounds / pharmacology*
  • Humans
  • Hydantoins / chemistry*
  • Hydantoins / pharmacology
  • Imidazolidines / chemistry*
  • Imidazolidines / pharmacology
  • Male
  • Models, Molecular
  • Molecular Structure
  • Nitriles / chemistry
  • Nitriles / pharmacology
  • Prostatic Neoplasms / drug therapy*
  • Receptors, Androgen / drug effects
  • Recombinant Proteins / drug effects
  • Stereoisomerism
  • Structure-Activity Relationship
  • Tosyl Compounds / chemistry
  • Tosyl Compounds / pharmacology
  • Tumor Cells, Cultured

Substances

  • Androgen Antagonists
  • Anilides
  • Ferrous Compounds
  • Hydantoins
  • Imidazolidines
  • Nitriles
  • Receptors, Androgen
  • Recombinant Proteins
  • Tosyl Compounds
  • nilutamide
  • bicalutamide